September 11th 2025
From 2017 to 2023, women were especially underrepresented in trials in arrhythmia, coronary heart disease, acute coronary syndrome, and heart failure.
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer
Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms
Ultrasound Safer Than MRI to Monitor Rheumatoid Arthritis in Pregnancy
ACR Study: Childhood Abuse Increases the Risk of Lupus in Women